{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,7]],"date-time":"2025-05-07T10:54:41Z","timestamp":1746615281583,"version":"3.37.3"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2024,11,29]],"date-time":"2024-11-29T00:00:00Z","timestamp":1732838400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,11,29]],"date-time":"2024-11-29T00:00:00Z","timestamp":1732838400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000053","name":"U.S. Department of Health & Human Services | NIH | National Eye Institute","doi-asserted-by":"publisher","award":["T32 EY024236"],"award-info":[{"award-number":["T32 EY024236"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001818","name":"Research to Prevent Blindness","doi-asserted-by":"publisher","award":["P30EY025585(BA-A)","P30EY025585(BA-A)"],"award-info":[{"award-number":["P30EY025585(BA-A)","P30EY025585(BA-A)"]}],"id":[{"id":"10.13039\/100001818","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eye"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1038\/s41433-024-03508-0","type":"journal-article","created":{"date-parts":[[2024,11,29]],"date-time":"2024-11-29T21:21:42Z","timestamp":1732915302000},"page":"505-515","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Prevalence and diversity of retinal disease in adults with Down syndrome"],"prefix":"10.1038","volume":"39","author":[{"given":"Michael J.","family":"Foster","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-5306-3982","authenticated-orcid":false,"given":"Jeffrey","family":"Chu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacqueline","family":"Shaia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rishi P.","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0458-4181","authenticated-orcid":false,"given":"Katherine E.","family":"Talcott","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,11,29]]},"reference":[{"key":"3508_CR1","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s12929-015-0138-y","volume":"22","author":"A Asim","year":"2015","unstructured":"Asim A, Kumar A, Muthuswamy S, Jain S, Agarwal S. Down syndrome: an insight of the disease. J Biomed Sci. 2015;22:41. https:\/\/doi.org\/10.1186\/s12929-015-0138-y.","journal-title":"J Biomed Sci"},{"key":"3508_CR2","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1016\/j.jpeds.2013.06.013","volume":"163","author":"AP Presson","year":"2013","unstructured":"Presson AP, Partyka G, Jensen KM, Devine OJ, Rasmussen SA, McCabe LL, et al. Current estimate of Down Syndrome population prevalence in the United States. J Pediatr. 2013;163:1163\u20138. https:\/\/doi.org\/10.1016\/j.jpeds.2013.06.013.","journal-title":"J Pediatr"},{"key":"3508_CR3","unstructured":"Akhtar F, Bokhari SRA Down Syndrome. StatPearls. Treasure Island (FL): StatPearls Publishing; 2022. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK526016\/."},{"key":"3508_CR4","doi-asserted-by":"publisher","first-page":"2556","DOI":"10.1056\/NEJMcp0900134","volume":"360","author":"DA Driscoll","year":"2009","unstructured":"Driscoll DA, Gross S. Clinical practice. Prenatal screening for aneuploidy. N Engl J Med. 2009;360:2556\u201362. https:\/\/doi.org\/10.1056\/NEJMcp0900134.","journal-title":"N Engl J Med"},{"key":"3508_CR5","doi-asserted-by":"publisher","first-page":"205.e1","DOI":"10.1016\/j.ajog.2010.12.060","volume":"204","author":"M Ehrich","year":"2011","unstructured":"Ehrich M, Deciu C, Zwiefelhofer T, Tynan JA, Cagasan L, Tim R, et al. Noninvasive detection of fetal trisomy 21 by sequencing of DNA in maternal blood: a study in a clinical setting. Am J Obstet Gynecol. 2011;204:205.e1\u201311. https:\/\/doi.org\/10.1016\/j.ajog.2010.12.060.","journal-title":"Am J Obstet Gynecol"},{"key":"3508_CR6","unstructured":"National Human Genome Research Institute. Learning about Down syndrome. 2010. http:\/\/www.genome.gov\/19517824#3."},{"key":"3508_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.dhjo.2020.100947","volume":"13","author":"SD Landes","year":"2020","unstructured":"Landes SD, Stevens JD, Turk MA. Cause of death in adults with Down syndrome in the United States. Disabil Health J. 2020;13:100947. https:\/\/doi.org\/10.1016\/j.dhjo.2020.100947.","journal-title":"Disabil Health J"},{"key":"3508_CR8","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1038\/gim.2016.127","volume":"19","author":"G de Graaf","year":"2017","unstructured":"de Graaf G, Buckley F, Skotko BG. Estimation of the number of people with Down syndrome in the United States. Genet Med. 2017;19:439\u201347. https:\/\/doi.org\/10.1038\/gim.2016.127.","journal-title":"Genet Med"},{"key":"3508_CR9","doi-asserted-by":"crossref","unstructured":"Xu J, Murphy SL, Kochanek KD, Arias E. Mortality in the United States, 2021. NCHS Data Brief. 2022. PMID: 36598387.","DOI":"10.15620\/cdc:122516"},{"key":"3508_CR10","doi-asserted-by":"publisher","first-page":"341","DOI":"10.3390\/children10020341","volume":"10","author":"E Sun","year":"2023","unstructured":"Sun E, Kraus CL. The ophthalmic manifestations of Down syndrome. Children. 2023;10:341. https:\/\/doi.org\/10.3390\/children10020341.","journal-title":"Children"},{"key":"3508_CR11","doi-asserted-by":"publisher","first-page":"1859","DOI":"10.2147\/OPTH.S36685","volume":"6","author":"AO Adio","year":"2012","unstructured":"Adio AO, Wajuihian SO. Ophthalmic manifestations of children with Down syndrome in Port Harcourt, Nigeria. Clin Ophthalmol. 2012;6:1859\u201364. https:\/\/doi.org\/10.2147\/OPTH.S36685.","journal-title":"Clin Ophthalmol"},{"key":"3508_CR12","first-page":"14","volume":"47","author":"AT Liza-Sharmini","year":"2006","unstructured":"Liza-Sharmini AT, Azlan ZN, Zilfalil BA. Ocular findings in Malaysian children with Down syndrome. Singap Med J. 2006;47:14\u20139.","journal-title":"Singap Med J"},{"key":"3508_CR13","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/974253","volume":"2012","author":"SJ Krinsky-McHale","year":"2012","unstructured":"Krinsky-McHale SJ, Jenkins EC, Zigman WB, Silverman W. Ophthalmic disorders in adults with Down syndrome. Curr Gerontol Geriatr Res. 2012;2012:974253. https:\/\/doi.org\/10.1155\/2012\/974253.","journal-title":"Curr Gerontol Geriatr Res"},{"key":"3508_CR14","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.3390\/ijms22031170","volume":"22","author":"A Pugazhendhi","year":"2021","unstructured":"Pugazhendhi A, Hubbell M, Jairam P, Ambati B. Neovascular macular degeneration: a review of etiology, risk factors, and recent advances in research and therapy. Int J Mol Sci. 2021;22:1170. https:\/\/doi.org\/10.3390\/ijms22031170.","journal-title":"Int J Mol Sci"},{"key":"3508_CR15","doi-asserted-by":"publisher","first-page":"5764","DOI":"10.1523\/JNEUROSCI.6015-10.2011","volume":"31","author":"M Blank","year":"2011","unstructured":"Blank M, Fuerst PG, Stevens B, Nouri N, Kirkby L, Warrier D, et al. The Down syndrome critical region regulates retinogeniculate refinement. J Neurosci. 2011;31:5764\u201376. https:\/\/doi.org\/10.1523\/JNEUROSCI.6015-10.2011.","journal-title":"J Neurosci"},{"key":"3508_CR16","doi-asserted-by":"publisher","DOI":"10.3389\/fbioe.2020.564057","volume":"8","author":"FY Hu","year":"2020","unstructured":"Hu FY, Gao FJ, Xu P, Zhang SH, Wu JH. Cell development deficiency and gene expression dysregulation of trisomy 21 retina revealed by single-nucleus RNA sequencing. Front Bioeng Biotechnol. 2020;8:564057. https:\/\/doi.org\/10.3389\/fbioe.2020.564057.","journal-title":"Front Bioeng Biotechnol"},{"key":"3508_CR17","doi-asserted-by":"publisher","first-page":"5640","DOI":"10.1523\/JNEUROSCI.2202-14.2015","volume":"35","author":"S Li","year":"2015","unstructured":"Li S, Sukeena JM, Simmons AB, Hansen EJ, Nuhn RE, Samuels IS, et al. DSCAM promotes refinement in the mouse retina through cell death and restriction of exploring dendrites. J Neurosci. 2015;35:5640\u201354. https:\/\/doi.org\/10.1523\/JNEUROSCI.2202-14.2015.","journal-title":"J Neurosci"},{"key":"3508_CR18","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.1167\/iovs.15-18395","volume":"57","author":"AB Simmons","year":"2016","unstructured":"Simmons AB, Merrill MM, Reed JC, Deans MR, Edwards MM, Fuerst PG. Defective angiogenesis and intraretinal bleeding in mouse models with disrupted inner retinal lamination. Investig Ophthalmol Vis Sci. 2016;57:1563\u201377. https:\/\/doi.org\/10.1167\/iovs.15-18395.","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"3508_CR19","doi-asserted-by":"publisher","first-page":"2775","DOI":"10.1093\/hmg\/ddt125","volume":"22","author":"A Laguna","year":"2013","unstructured":"Laguna A, Barallobre MJ, Marchena M\u00c1, Mateus C, Ram\u00edrez E, Mart\u00ednez-Cue C, et al. Triplication of DYRK1A causes retinal structural and functional alterations in Down syndrome. Hum Mol Genet. 2013;22:2775\u201384. https:\/\/doi.org\/10.1093\/hmg\/ddt125.","journal-title":"Hum Mol Genet"},{"key":"3508_CR20","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1167\/iovs.61.5.25","volume":"61","author":"DB Victorino","year":"2020","unstructured":"Victorino DB, Scott-McKean JJ, Johnson MW, Costa ACS. Quantitative analysis of retinal structure and function in two chromosomally altered mouse models of Down syndrome. Investig Ophthalmol Vis Sci. 2020;61:25. https:\/\/doi.org\/10.1167\/iovs.61.5.25.","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"3508_CR21","doi-asserted-by":"publisher","first-page":"1867","DOI":"10.1016\/j.celrep.2018.04.008","volume":"23","author":"EJ Rozen","year":"2018","unstructured":"Rozen EJ, Roewenstrunk J, Barallobre MJ, Di Vona C, Jung C, Figueiredo AF, et al. DYRK1A kinase positively regulates angiogenic responses in endothelial cells. Cell Rep. 2018;23:1867\u201378. https:\/\/doi.org\/10.1016\/j.celrep.2018.04.008.","journal-title":"Cell Rep"},{"key":"3508_CR22","doi-asserted-by":"publisher","first-page":"3300","DOI":"10.1167\/iovs.09-4465","volume":"51","author":"JJ Scott-McKean","year":"2010","unstructured":"Scott-McKean JJ, Chang B, Hurd RE, Nusinowitz S, Schmidt C, Davisson MT, et al. The mouse model of Down syndrome Ts65Dn presents visual deficits as assessed by pattern visual evoked potentials. Investig Ophthalmol Vis Sci. 2010;51:3300\u20138. https:\/\/doi.org\/10.1167\/iovs.09-4465.","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"3508_CR23","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1001\/archopht.1976.03910030378005","volume":"94","author":"A Ahmad","year":"1976","unstructured":"Ahmad A, Pruett RC. The fundus in mongolism. Arch Ophthalmol. 1976;94:772\u20136. https:\/\/doi.org\/10.1001\/archopht.1976.03910030378005.","journal-title":"Arch Ophthalmol"},{"key":"3508_CR24","first-page":"808","volume":"78","author":"EA Jaeger","year":"1980","unstructured":"Jaeger EA. Ocular findings in Down\u2019s syndrome. Trans Am Ophthalmol Soc. 1980;78:808\u201345.","journal-title":"Trans Am Ophthalmol Soc"},{"key":"3508_CR25","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1097\/00006324-197908000-00005","volume":"56","author":"MC Sherk","year":"1979","unstructured":"Sherk MC, Williams TD. Disc vascularity in Down\u2019s syndrome. Am J Optom Physiol Opt. 1979;56:509\u201311. https:\/\/doi.org\/10.1097\/00006324-197908000-00005.","journal-title":"Am J Optom Physiol Opt"},{"key":"3508_CR26","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1001\/archopht.1973.01000040271001","volume":"89","author":"EJ Williams","year":"1973","unstructured":"Williams EJ, McCormick AQ, Tischler B. Retinal vessels in Down\u2019s syndrome. Arch Ophthalmol. 1973;89:269\u201371. https:\/\/doi.org\/10.1001\/archopht.1973.01000040271001.","journal-title":"Arch Ophthalmol"},{"key":"3508_CR27","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1016\/j.oftale.2021.01.002","volume":"96","author":"O Esteban","year":"2021","unstructured":"Esteban O, Marcuello C, Martinez M, Lavilla L, Marco S, Ascaso FJ. Macular and choroidal thickness in Down syndrome by swept-source optical coherence tomography (SS-OCT). Arch Soc Esp Oftalmol 2021;96:618\u201322. https:\/\/doi.org\/10.1016\/j.oftale.2021.01.002.","journal-title":"Arch Soc Esp Oftalmol"},{"key":"3508_CR28","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1016\/j.dadm.2019.08.007","volume":"11","author":"MJ Walpert","year":"2019","unstructured":"Walpert MJ, Normando EM, Annus T, Jennings SR, Wilson LR, Watson P. et al. Age-related retinal thickness in Down's syndrome: a high-risk population for dementia. Alzheimer's Dementia Diagnosis Assessment Disease Monitoring. 2019;11:744\u201351.","journal-title":"Alzheimer's Dementia Diagnosis Assessment Disease Monitoring"},{"key":"3508_CR29","doi-asserted-by":"publisher","first-page":"239","DOI":"10.3389\/fnbeh.2015.00239","volume":"9","author":"MS Rafii","year":"2015","unstructured":"Rafii MS, Wishnek H, Brewer JB, Donohue MC, Ness S, Mobley WC, et al. The Down syndrome biomarker initiative (DSBI) pilot: proof of concept for deep phenotyping of Alzheimer\u2019s disease biomarkers in Down syndrome. Front Behav Neurosci. 2015;9:239. https:\/\/doi.org\/10.3389\/fnbeh.2015.00239.","journal-title":"Front Behav Neurosci"},{"key":"3508_CR30","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/s0002-9394(14)72015-x","volume":"122","author":"RP da Cunha","year":"1996","unstructured":"da Cunha RP, Moreira JB. Ocular findings in Down\u2019s syndrome. Am J Ophthalmol. 1996;122:236\u201344. https:\/\/doi.org\/10.1016\/s0002-9394(14)72015-x.","journal-title":"Am J Ophthalmol"},{"key":"3508_CR31","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1038\/sj.eye.6700208","volume":"16","author":"JH Kim","year":"2002","unstructured":"Kim JH, Hwang JM, Kim HJ, Yu YS. Characteristic ocular findings in Asian children with Down syndrome. Eye. 2002;16:710\u20134. https:\/\/doi.org\/10.1038\/sj.eye.6700208.","journal-title":"Eye"},{"key":"3508_CR32","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1038\/s41433-021-01883-6","volume":"36","author":"R Nicholson","year":"2022","unstructured":"Nicholson R, Osborne D, Fairhead L, Beed L, Hill CM, Lee H. Segmentation of the foveal and parafoveal retinal architecture using handheld spectral-domain optical coherence tomography in children with Down syndrome. Eye. 2022;36:963\u20138. https:\/\/doi.org\/10.1038\/s41433-021-01883-6.","journal-title":"Eye"},{"key":"3508_CR33","doi-asserted-by":"publisher","first-page":"2317","DOI":"10.1007\/s00417-015-3088-x","volume":"253","author":"S O\u2019Brien","year":"2015","unstructured":"O\u2019Brien S, Wang J, Smith HA, Donaldson DL, Haider KM, Roberts GJ, et al. Macular structural characteristics in children with Down syndrome. Graefes Arch Clin Exp Ophthalmol. 2015;253:2317\u201323. https:\/\/doi.org\/10.1007\/s00417-015-3088-x.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"3508_CR34","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/9726261","volume":"2020","author":"A Ugurlu","year":"2020","unstructured":"Ugurlu A, Altinkurt E. Ophthalmologic manifestations and retinal findings in children with Down syndrome. J Ophthalmol. 2020;2020:9726261. https:\/\/doi.org\/10.1155\/2020\/9726261.","journal-title":"J Ophthalmol"},{"key":"3508_CR35","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1167\/iovs.15-18532","volume":"57","author":"AH Weiss","year":"2016","unstructured":"Weiss AH, Kelly JP, Phillips JO. Infantile nystagmus and abnormalities of conjugate eye movements in Down syndrome. Investig Ophthalmol Vis Sci. 2016;57:1301\u20139. https:\/\/doi.org\/10.1167\/iovs.15-18532.","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"3508_CR36","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1080\/02713683.2019.1597128","volume":"44","author":"S Mangalesh","year":"2019","unstructured":"Mangalesh S, Vinekar A, Jayadev C, Kemmanu V, Bhat M, Sivakumar M, et al. Spectral domain optical coherence tomography in detecting sub-clinical retinal findings in Asian Indian Children with Down Syndrome. Curr Eye Res. 2019;44:901\u20137. https:\/\/doi.org\/10.1080\/02713683.2019.1597128.","journal-title":"Curr Eye Res"},{"key":"3508_CR37","doi-asserted-by":"publisher","first-page":"633","DOI":"10.3389\/fneur.2019.00633","volume":"10","author":"L Postolache","year":"2019","unstructured":"Postolache L. Abnormalities of the optic nerve in Down Syndrome and associations with visual acuity. Front Neurol. 2019;10:633. https:\/\/doi.org\/10.3389\/fneur.2019.00633.","journal-title":"Front Neurol"},{"key":"3508_CR38","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1111\/ceo.13327","volume":"46","author":"L Kessel","year":"2018","unstructured":"Kessel L, Hamann S, Wegener M, Tong J, Fraser CL. Microcystic macular oedema in optic neuropathy: case series and literature review. Clin Exp Ophthalmol. 2018;46:1075\u201386. https:\/\/doi.org\/10.1111\/ceo.13327.","journal-title":"Clin Exp Ophthalmol"},{"key":"3508_CR39","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2023.1128811","volume":"10","author":"CD Haydinger","year":"2023","unstructured":"Haydinger CD, Ferreira LB, Williams KA, Smith JR. Mechanisms of macular edema. Front Med. 2023;10:1128811. https:\/\/doi.org\/10.3389\/fmed.2023.1128811.","journal-title":"Front Med"},{"key":"3508_CR40","doi-asserted-by":"publisher","first-page":"82","DOI":"10.4161\/cam.22480","volume":"7","author":"MM Edwards","year":"2013","unstructured":"Edwards MM, Lefebvre O. Laminins and retinal vascular development. Cell Adh Migr. 2013;7:82\u20139. https:\/\/doi.org\/10.4161\/cam.22480.","journal-title":"Cell Adh Migr"},{"key":"3508_CR41","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1038\/sj.eye.6702851","volume":"21","author":"D Taylor","year":"2007","unstructured":"Taylor D. Developmental abnormalities of the optic nerve and chiasm. Eye. 2007;21:1271\u201384. https:\/\/doi.org\/10.1038\/sj.eye.6702851.","journal-title":"Eye"},{"key":"3508_CR42","doi-asserted-by":"publisher","first-page":"2892","DOI":"10.2337\/dc22-0482","volume":"45","author":"AA Aslam","year":"2022","unstructured":"Aslam AA, Baksh RA, Pape SE, Strydom A, Gulliford MC, Chan LF. GO-DS21 consortium. diabetes and obesity in Down Syndrome across the lifespan: a retrospective cohort study using U.K. electronic health records. Diabetes Care. 2022;45:2892\u20139. https:\/\/doi.org\/10.2337\/dc22-0482.","journal-title":"Diabetes Care"},{"key":"3508_CR43","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2022.877711","volume":"10","author":"Z Hasina","year":"2022","unstructured":"Hasina Z, Wang N, Wang CC. Developmental neuropathology and neurodegeneration of Down syndrome: current knowledge in humans. Front Cell Dev Biol. 2022;10:877711. https:\/\/doi.org\/10.3389\/fcell.2022.877711.","journal-title":"Front Cell Dev Biol"},{"key":"3508_CR44","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.stem.2021.12.002","volume":"29","author":"HS Meharena","year":"2022","unstructured":"Meharena HS, Marco A, Dileep V, Lockshin ER, Akatsu GY, Mullahoo J, et al. Down-syndrome-induced senescence disrupts the nuclear architecture of neural progenitors. Cell Stem Cell. 2022;29:116\u2013130.e7. https:\/\/doi.org\/10.1016\/j.stem.2021.12.002.","journal-title":"Cell Stem Cell"}],"container-title":["Eye"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41433-024-03508-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41433-024-03508-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41433-024-03508-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,4]],"date-time":"2025-02-04T10:13:19Z","timestamp":1738663999000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41433-024-03508-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,29]]},"references-count":44,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["3508"],"URL":"https:\/\/doi.org\/10.1038\/s41433-024-03508-0","relation":{},"ISSN":["0950-222X","1476-5454"],"issn-type":[{"type":"print","value":"0950-222X"},{"type":"electronic","value":"1476-5454"}],"subject":[],"published":{"date-parts":[[2024,11,29]]},"assertion":[{"value":"8 August 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 August 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 November 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 November 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"KT: Genentech (speaker\u2019s bureau, consultant), Zeiss (grant), Eyepoint (consultant), Apellis (consultant), Regenxbio (consultant). Rishi Singh reports personal fees from Genentech\/Roche, Alcon, Novartis, Regeneron, Asclepix, Gyroscope, Bausch and Lomb, and Apellis. Katherine Talcott reports personal fees from Genentech\/Roche, Apellis, and EyePoint and research fees from Zeiss and Regenxbio.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}